BTC Health Ltd (ASX: BTC) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

BTC Health Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $12.96 million
P/E Ratio N/A
Dividend Yield 0.00%
Shares Outstanding 324.12 million
Earnings per share -0.030
Dividend per share N/A
Year To Date Return -23.08%
Earnings Yield N/A
Franking -
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • BTC Health Ltd (ASX: BTC)
    Latest News

    a woman
    ⏸️ Investing

    6 listed funds with tax free capital gains and dividends

    Pooled Development Funds offer attractive tax treatment but come with high risk.

    Read more »

    Dividend Payment History Data provided by Morningstar.

    Data provided by Morningstar.
    Ex-Date Amount Franking Type Payable
    05 Jul 2011 $0.0280 0.00% Special Cash 15 Jul 2011
    03 Sep 2010 $0.0140 0.00% Final 13 Sep 2010

    BTC ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About BTC Health Ltd

    BTC Health Ltd is a pooled development fund. The company is seeking new investment opportunities in entities operating in the biotechnology/life-science sectors. Its only operating segment is the making and managing of healthcare ventures.The company's product includes ambIT Infusion Pumps; episil oral liquid, Eldor, and its pipeline products ChloraSolv.

    BTC Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    18 Jul 2024 $0.04 $0.00 0.00% 130,027 $0.04 $0.04 $0.04
    16 Jul 2024 $0.04 $0.00 0.00% 200,697 $0.04 $0.04 $0.04
    15 Jul 2024 $0.04 $0.00 0.00% 99,636 $0.04 $0.04 $0.04
    12 Jul 2024 $0.04 $0.00 0.00% 30,027 $0.04 $0.04 $0.04
    10 Jul 2024 $0.04 $0.00 0.00% 12,314 $0.04 $0.04 $0.04
    09 Jul 2024 $0.04 $0.00 0.00% 37,690 $0.04 $0.04 $0.04
    04 Jul 2024 $0.04 $0.00 0.00% 38,537 $0.04 $0.04 $0.04
    03 Jul 2024 $0.04 $0.00 0.00% 24,000 $0.04 $0.04 $0.04
    02 Jul 2024 $0.04 $0.00 0.00% 37,463 $0.04 $0.04 $0.04
    27 Jun 2024 $0.04 $0.00 0.00% 20,000 $0.04 $0.04 $0.04
    26 Jun 2024 $0.04 $0.00 0.00% 141,515 $0.04 $0.04 $0.04
    25 Jun 2024 $0.04 $0.00 0.00% 50 $0.04 $0.04 $0.04
    24 Jun 2024 $0.04 $0.00 0.00% 206,832 $0.04 $0.04 $0.04
    21 Jun 2024 $0.04 $0.00 0.00% 26,344 $0.04 $0.04 $0.04
    20 Jun 2024 $0.04 $0.00 0.00% 1,184 $0.04 $0.04 $0.04
    18 Jun 2024 $0.04 $0.00 0.00% 86,239 $0.04 $0.04 $0.04

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    27 Jun 2024 Richard Treagus Buy 185,515 $7,094
    On-market trade.
    22 Nov 2023 Richard Treagus Issued 10,000,000 $600,000
    Issue of options.

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Dr Richard Spencer Treagus Executive ChairmanExecutive Director Aug 2014
    Dr Treagus has over 25 years of experience in all aspects of the international pharmaceutical and biotechnology industry.
    Mr Brendan York Non-Executive Director Oct 2022
    Mr York is a financial executive with 20 years of experience across public and private businesses.
    Ms Felicity McNeill Non-Executive Director Oct 2022
    Ms McNeill is a senior executive with 25 years of experience across the public and private sector including almost 15 years in the regulatory and subsidy systems for medicines, vaccines, devices and diagnostics in Australia.
    Ms Tracy Weimar Company Secretary Aug 2023
    -
    Tracy Weimar Company Secretary
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    National Nominees Limited 84,265,587 29.90%
    Mrs Karen Elizabeth Treagus <Treagus Family A/C> 29,376,000 10.42%
    Sigma Company Limited 16,856,467 5.98%
    Namarong Investments Pty Ltd The Hansen Investment 15,000,000 5.32%
    J P Morgan Nominees Australia Pty Limited 10,150,000 3.60%
    Mr Campbell Dinwoodie Taylor 8,941,314 3.17%
    Mr Thomas Christopher Fennell 8,682,787 3.08%
    Sigma Company Limited i 8,143,533 2.89%
    Argus Nominees Pty Ltd <The Halstead Super Fund A/C> 5,500,000 1.95%
    Mrs Susan Maree Whiting 5,300,000 1.88%
    Windarri Investments Pty Ltd <Herz Family A/C> 4,213,727 1.50%
    Abeille Investments Pty Limited <Wright Family S/F A/C> 3,800,000 1.35%
    Mr Nicholas Dermott Mcdonald 3,644,239 1.29%
    Sigma Company Limited ii 3,627,553 1.29%
    Namarong Investments Pty Ltd Hansen Investment 3,125,000 1.11%
    Linwierik Investments Pty Ltd 2,600,000 0.92%
    Chanuk Nominees Pty Ltd <Fisherman'S Foundation A/C> 2,080,000 0.74%
    Pritdown Pty Ltd <Mcdonald Super Fund A/C> 2,000,000 0.71%
    BNP Paribas Nominees Pty Ltd Hub24 Custodial Serv Ltd <Drp A/C> 1,780,600 0.63%
    Mr Nicholas Dermott Mcdonald i 1,604,892 0.57%

    Profile

    since

    Note